Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

7.48
Delayed Data
As of Aug 27
 +0.28 / +3.89%
Today’s Change
6.23
Today|||52-Week Range
25.60
-53.37%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close7.20
Today’s open7.26
Day’s range7.12 - 7.50
Volume568,931
Average volume (3 months)846,110
Market cap$373.8M
Dividend yield--
Data as of 08/27/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)-4.81%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book2.67

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...+0.87+3.38%
SCLNSciClone Pharmaceuti...+0.21+2.77%
ADMSAdamas Pharmaceutica...+0.33+1.67%
IGIGI Laboratories Inc+0.36+4.94%
Data as of 08/27/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
CFO, Secretary, CAO &
General Counsel
David L. Szekeres
Corporate headquarters
San Diego, California

Forecasts

Partner Offers